Search - tctmd.com

Displaying 61 - 80 of 2043

Sort: Relevancy | Date

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Conference News ESC 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Todd Neale

August 31, 2025

Presentation ESC 2025

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Presenter: Brian Bergmark

August 30, 2025

News Conference News ESC 2025

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Caitlin E. Cox

August 29, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

DAPT De-escalation Success Varies by Sex: Meta-analysis

Yael L. Maxwell

August 21, 2025

News Daily News

Healthcare Expenses Increase After GLP-1 Prescription

L.A. McKeown

August 18, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Daily News

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Yael L. Maxwell

August 14, 2025

News Daily News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

Todd Neale

August 11, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Conference News SCCT 2025

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR

Yael L. Maxwell

July 28, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

Advertisement

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Essence-TIMI 73b: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

AI-Supported Coaching Shows Promise for Improving Glycemic Control

What’s Going to Be Hot at ESC Congress 2025?

August 2025 Dispatch for the CV Team

DAPT De-escalation Success Varies by Sex: Meta-analysis

Healthcare Expenses Increase After GLP-1 Prescription

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

TCTMD’s Top 10 Most Popular Stories for July 2025

Heart Disease Treatment Costs $100 Billion per Year in the US

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content